Home Duke University Press
 QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Neuro Oncol 2005 7(1):12-19; DOI:10.1215/S1152851704000079
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reddick, W. E.
Right arrow Articles by Mulhern, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Duke University Press

Imaging

Atypical white matter volume development in children following craniospinal irradiation

Wilburn E. Reddick2, John O. Glass, Shawna L. Palmer, Shingjie Wu, Amar Gajjar, James W. Langston, Larry E. Kun, Xiaoping Xiong and Raymond K. Mulhern

Departments of Radiological Sciences (W.E.R., J.O.G., J.W.L., L.E.K.), Behavioral Medicine (S.L.P., R.K.M.), Biostatistics (S.W., X.X.), and Hematology-Oncology (A.G.), St. Jude Children's Research Hospital, Memphis, TN 38105; Departments of Electrical and Computer Engineering (W.E.R.) and Biomedical Engineering (W.E.R.), University of Memphis, Memphis, TN 38152; USA

2 Address correspondence to Wilburn E. Reddick, Department of Radiological Sciences (MS #212), St. Jude Children's Research Hospital, 332 N. Lauderdale St., Memphis, TN 38105-2794, USA (gene.reddick{at}stjude.org).

Abstract

Most children with medulloblastoma (MB), the second most common pediatric brain tumor, have a 70% probability of survival. However, survivors who receive aggressive therapy are at significant risk of cognitive deficits that have been associated with lower volumes of normalappearing white matter (NAWM). We hypothesized that cranial irradiation inhibited normal brain volume development in these survivors. We retrospectively analyzed 324 MRI studies of 52 patients with histologically proven MB treated with surgery and 35 to 40 Gy craniospinal irradiation, with or without chemotherapy. The volume of NAWM and that of cerebrospinal fluid were quantified from a single index section and compared with those of healthy, age-similar control subjects. A quadratic random coefficient model was used to identify trends in brain volume with increasing age. Patients treated for MB at younger ages demonstrated substantially less development of NAWM volume than did their healthy peers. Younger age at the time of irradiation and the need for a ventricular shunt were significantly associated with reduced NAWM volume. NAWM and craniospinal fluid volume differences between patients who had shunts and those without resolved over a period of four to five years. NAWM volume is known to be associated with neurocognitive test performance, which shows deficiencies after cranial irradiation early in life. Therefore, volumetric monitoring of brain development can be used to guide the care of survivors, assess the toxicity of previous and current clinical trials, and aid in the design of therapies that minimize toxicity.




This article has been cited by other articles:


Home page
J Pediatr PsycholHome page
S. L. Palmer, W. E. Reddick, and A. Gajjar
Understanding the Cognitive Impact on Children Who are Treated for Medulloblastoma
J. Pediatr. Psychol., October 1, 2007; 32(9): 1040 - 1049.
[Abstract] [Full Text] [PDF]


Home page
J Pediatr PsycholHome page
B. P. Daly and R. T. Brown
Scholarly Literature Review: Management of Neurocognitive Late Effects with Stimulant Medication
J. Pediatr. Psychol., October 1, 2007; 32(9): 1111 - 1126.
[Abstract] [Full Text] [PDF]




  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 2005 by Society for Neuro-Oncology